A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 10, Pages 1309-1319
Publisher
SAGE Publications
Online
2017-05-08
DOI
10.1177/1352458517707265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
- (2016) Xavier Giffroy et al. ACTA NEUROLOGICA BELGICA
- Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis
- (2016) Xavier Giffroy et al. BMC Neurology
- Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems
- (2016) Regina Schlaeger et al. CLINICAL NEUROPHYSIOLOGY
- Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy
- (2016) R. Iodice et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- Advanced MRI and staging of multiple sclerosis lesions
- (2016) Martina Absinta et al. Nature Reviews Neurology
- The contemporary spectrum of multiple sclerosis misdiagnosis
- (2016) Andrew J. Solomon et al. NEUROLOGY
- Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis
- (2016) Mona Sadeghian et al. Scientific Reports
- Biomarkers in multiple sclerosis
- (2015) William J. Housley et al. CLINICAL IMMUNOLOGY
- Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization
- (2015) S Amur et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Multimodal neurophysiological evaluation of primary progressive multiple sclerosis – An increasingly valid biomarker, with limits
- (2015) L.J.W. Canham et al. Multiple Sclerosis and Related Disorders
- Remyelination Therapy in Multiple Sclerosis
- (2015) Danielle E. Harlow et al. Frontiers in Neurology
- Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years
- (2014) Regina Schlaeger et al. Multiple Sclerosis Journal
- The visual pathway as a model to understand brain damage in multiple sclerosis
- (2014) E H Martínez-Lapiscina et al. Multiple Sclerosis Journal
- Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
- (2014) Giovanni Di Maggio et al. Multiple Sclerosis Journal
- Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis
- (2013) Martin Hardmeier et al. BRAIN TOPOGRAPHY
- The utility of multimodal evoked potentials in multiple sclerosis prognostication
- (2013) Sudarshini Ramanathan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Central motor conduction time may predict response to fampridine in patients with multiple sclerosis
- (2013) D. Zeller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis
- (2013) Regina Schlaeger et al. Multiple Sclerosis Journal
- Evoked potentials are of little use in the diagnosis or monitoring of MS: Yes
- (2013) Christopher McGuigan Multiple Sclerosis Journal
- Evoked potentials are of little use in the diagnosis or monitoring of MS: No
- (2013) Oscar Fernández et al. Multiple Sclerosis Journal
- Evoked potentials are of little use in the diagnosis or monitoring of MS: Commentary
- (2013) Michael Hutchinson Multiple Sclerosis Journal
- Uhthoff's phenomena in MS—clinical features and pathophysiology
- (2013) Teresa C. Frohman et al. Nature Reviews Neurology
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Demyelination affects temporal aspects of perception: An optic neuritis study
- (2011) Noa Raz et al. ANNALS OF NEUROLOGY
- Combined evoked potentials as markers and predictors of disability in early multiple sclerosis
- (2011) Regina Schlaeger et al. CLINICAL NEUROPHYSIOLOGY
- Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score
- (2011) Paolo Invernizzi et al. JOURNAL OF NEUROLOGY
- Simvastatin improves final visual outcome in acute optic neuritis: a randomized study
- (2011) Anna Tsakiri et al. Multiple Sclerosis Journal
- Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis
- (2011) N. Margaritella et al. NEUROLOGICAL SCIENCES
- Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis
- (2010) C M Rice et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Natalizumab restores evoked potential abnormalities in patients with relapsing–remitting multiple sclerosis
- (2010) Sven G Meuth et al. Multiple Sclerosis Journal
- Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
- (2009) R. Pelayo et al. Multiple Sclerosis Journal
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Multimodal evoked potentials measure and predict disability progression in early relapsing–remitting multiple sclerosis
- (2008) P Jung et al. Multiple Sclerosis Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now